Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
Clinical trial NCT03099356 · RECRUITING
Trial details
- NCT number
- NCT03099356
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2026-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.